ruthenium has been researched along with 4-cymene in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (3.37) | 29.6817 |
2010's | 58 (65.17) | 24.3611 |
2020's | 28 (31.46) | 2.80 |
Authors | Studies |
---|---|
Li, F; Li, Y; Li, Z; Tao, F; Wang, Q | 1 |
Ang, WH; Dyson, PJ; Juillerat-Jeanneret, L; Lagopoulos, L; Phillips, AD; Sava, G; Scolaro, C; Scopelliti, R; Vock, CA | 1 |
Brabec, V; Castellano-Castillo, M; Kasparkova, J; Kostrhunova, H; Malinge, JM; Marini, V; Sadler, PJ | 1 |
Beckford, F; Crowell, V; Didion, J; Dourth, D; Gerasimchuk, N; Gonzalez-Sarrías, A; Seeram, NP; Shaloski, M; Thessing, J; Woods, J | 1 |
Barilleau, L; Fosse, C; Haquette, P; Madern, N; Salmain, M; Talbi, B | 1 |
Barry, NP; Dyson, PJ; Therrien, B; Zava, O | 1 |
Beller, M; Jagadeesh, RV; Junge, H; Junge, K; Surkus, AE; Westerhaus, FA; Wienhöfer, G | 1 |
Kishan, R; Nethaji, M; Singh, T; Thirupathi, N | 1 |
Furrer, J; Paul, LE; Therrien, B | 1 |
Aliende, C; Biver, T; Busto, N; Espino, G; García, B; Gaspar, JF; Jalón, FA; Leal, JM; Manzano, BR; Martins, C; Rodríguez, AM; Valladolid, J | 1 |
Ackermann, L; Pospech, J; Potukuchi, HK | 1 |
Che, CM; Choi, MK; Guo, Z; Huang, JS; Lo, VK; Yu, WY | 1 |
Bette, M; Block, M; Kaluđerović, GN; Ludwig, G; Paschke, R; Steinborn, D | 1 |
Enyedy, ÉA; Hartinger, CG; Jakupec, MA; Kandioller, W; Keppler, BK; Kurzwernhart, A; Novak, M | 1 |
Fukuzawa, S; Inomata, S; Ogata, K | 1 |
Červený, J; Goncharova, II; Januščák, J; Kačer, P; Kuzma, M; Matoušek, V; Novák, P; Pecháček, J; Přech, J; Šot, P; Urbanová, M; Václavík, J; Vilhanová, B | 1 |
Chen, Y; Hou, Y; Jiang, G; Lei, W; Li, C; Wang, X; Zhang, B; Zhou, Q | 3 |
Adeniyi, AA; Ajibade, PA | 1 |
Enyedy, EA; Hartinger, CG; Jakusch, T; Kandioller, W; Keppler, BK; Kiss, T; Sija, E | 1 |
Biver, T; Busto, N; Carrión, MC; Espino, G; García, B; Jalón, FA; Leal, JM; Lozano, HJ; Manzano, BR; Martínez-Alonso, M; Rodríguez, AM; Valladolid, J | 1 |
Fu, L; Peng, Z; Xie, X; Zhang, L; Zhang, Z | 1 |
Akbarsha, MA; Ganeshpandian, M; Loganathan, R; Palaniandavar, M; Riyasdeen, A; Suresh, E | 1 |
Arslan, F; Dayan, S; Kalaycioglu, NO; Kayacı, N | 1 |
Adhireksan, Z; Ang, WH; Campomanes, P; Clavel, CM; Davey, CA; Davey, GE; Dröge, P; Dyson, PJ; Groessl, M; Nazarov, AA; Rothlisberger, U; Yeo, CH; Yu, H | 1 |
Chi, KW; Jeong, YJ; Jo, JH; Kang, SC; Lah, MS; Mishra, A | 1 |
Biersack, B; Mahal, K; Schobert, R; Spoerlein-Guettler, C | 1 |
Matsuoka, A; Naka, H; Noyori, R; Sandoval, CA; Uchiyama, M | 1 |
Clavel, CM; Dyson, PJ; Griffioen, AW; Nowak-Sliwinska, P; Păunescu, E; Scopelliti, R | 2 |
Matsui, K; Shibuya, M; Yamamoto, Y | 1 |
Blazevski, J; Eichhorn, T; Kaluđerović, GN; Momcilovic, M; Schmidt, H; Stosic-Grujicic, S | 1 |
Arcangeli, A; Contel, M; Fernández-Gallardo, J; Guerri, A; Massai, L; Messori, L; Pillozzi, S | 1 |
Clavel, CM; Dyson, PJ; Griffioen, AW; Nowak-Sliwinska, P; Păunescu, E; te Winkel, MT | 1 |
Yamamoto, Y; Yohda, M | 1 |
Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Cheminel, T; Grozav, A; Therrien, B | 1 |
Plavec, J; Seršen, S; Šket, P; Turel, I | 1 |
Aranđelović, S; Gasser, G; Gligorijević, N; Grgurić-Šipka, S; Nikolić, S; Radulović, S; Rangasamy, L | 1 |
Borrmann, H; Leopold, H; Schleicher, D; Strassner, T; Tronnier, A | 1 |
Bényei, AC; Buglyó, P; Kasparkova, J; Kováts, É; Muchova, TR; Novohradsky, V; Parajdi-Losonczi, PL; Timári, I | 1 |
Fitzgerald Hughes, D; Marmion, CJ; Romero-Canelón, I; Sadler, PJ; Twamley, B; Ude, Z | 1 |
Čermáková, E; Dyson, PJ; Nowak-Sliwinska, P; Řezáčová, M; Stíbal, D; Süss-Fink, G; Therrien, B; Tomšík, P | 1 |
Chatterjee, S; Karmakar, S; Mukherjee, A; Purkait, K | 1 |
Dyson, PJ; Govender, P; Riedel, T; Smith, GS | 1 |
Anderson, RF; Hartinger, CG; Jakupec, MA; Kandioller, W; Keppler, BK; Kim, K; Klapproth, E; Kubanik, M; Roller, A; Söhnel, T | 1 |
Caruso, A; Caruso, F; Gariboldi, MB; Marchetti, F; Monti, E; Pettinari, C; Pettinari, R; Ramani, MV; Rossi, M; Subbaraju, GV | 1 |
Allison, SJ; Ghandhi, L; Lord, RM; McGowan, PC; Pask, CM; Rafferty, K | 1 |
Gobec, S; Kljun, J; Kos, J; Mitrović, A; Sosič, I; Turel, I | 1 |
Ajibola Adeyemo, A; Bhat, IA; Kondaiah, P; Mukherjee, PS; Shettar, A | 1 |
Frias, C; Jones, PG; Keppler, BK; Misgeld, R; Ott, I; Prokop, A; Streciwilk, W; Terenzi, A | 1 |
Bhattacharyya, S; Mukherjee, A; Purkait, K | 1 |
Batchelor, LK; Biancalana, L; Bortoluzzi, M; Dyson, PJ; Funaioli, T; Marchetti, F; Pampaloni, G; Zacchini, S | 1 |
Adeyemo, AA; Bhat, IA; Kondaiah, P; Mukherjee, PS; Shettar, A | 1 |
Batchelor, LK; Biancalana, L; Ciancaleoni, G; Dyson, PJ; Marchetti, F; Pampaloni, G; Zacchini, S | 1 |
Carvalho, A; Fernandes, AR; Fernández, A; Fernández, JJ; Folgueira, M; Lenis-Rojas, OA; López Torres, M; Marques, F; Robalo, MP; Tomaz, AI; Vázquez-García, D; Yáñez, J | 1 |
Barrios, LA; Brissos, RF; Caballero, AB; Clavero, P; Gallen, A; Gamez, P; Grabulosa, A; Korrodi-Gregório, L; Muller, G; Pérez-Tomás, R; Soto-Cerrato, V | 1 |
Acharya, S; Khushvant, K; Mukherjee, A; Purkait, K; Sarkar, A | 1 |
Chien, CM; Ching, WM; Chou, CK; Haribabu, J; Hsu, SCN; Huang, YC; Karvembu, R; Sabapathi, G; Tsai, ML; Venuvanalingam, P | 1 |
Kuo, YC; Madaan, Y; Mondal, A; Moorthy, A; Paira, P; Roy, N; Sarkar, B | 1 |
Cao, K; Cui, S; Hou, Z; Huang, G; Kljun, J; Liu, Y; Sheng, Y; Sun, M; Turel, I; Yuan, S | 1 |
Dömötör, O; Enyedy, ÉA; Frank, É; Gál, GT; Gašparović, AČ; Kiss, MA; May, NV; Nové, M; Spengler, G | 1 |
Acharya, S; Ghosh, S; Maji, M; Mukherjee, A; Parambil, ARU; Singh, S | 1 |
Acharya, S; Bhattacharjee, A; Chakraborty, K; Mukherjee, A; Purkait, K | 1 |
Aoki, S; Balachandran, C; Ganguly, R; Konakanchi, R; Musthafa, M; Sreekanth, A | 1 |
Carissimi, G; Fuster, MG; García, G; Montalbán, MG; Pérez, SA; Pujante-Galián, MA; Víllora, G | 1 |
Bose, B; Mondal, A; Muthukumar, V; Paira, P; Roy, N; Sahoo, SK; Sen, U | 1 |
Hanif, M; Hartinger, CG; Leung, E; Riisom, M; Tong, KKH; Yano, E | 1 |
Acharya, S; Bhattacharya, I; Gupta, A; Maji, M; Mukherjee, A | 1 |
Garoufis, A; Kordias, D; Kougioumtzi, A; Magklara, A; Nikolaou, N; Tsolis, T; Ypsilantis, K | 1 |
Das, U; De, S; Kar, B; Paira, P; Panda, D; Pete, S; Roy, N; S K, AK; Sharma S, A | 1 |
Balakrishnan, N; Bhuvanesh, N; Echeverria, C; Gayathri, D; Haribabu, J; Karvembu, R; Mohamed Subarkhan, MK; Swaminathan, S | 1 |
Das, U; P K, A; Paira, P; Roy, N; Sahoo, SK; Varddhan, S | 1 |
Brindell, M; Ganeshpandian, M; Gopinath, P; Manjunathan, T; Mazuryk, O; Peters, S; Pillai, RS; Sumithaa, C | 1 |
Blasco, S; Estalayo-Adrián, S; Gunnlaugsson, T; la Cour Poulsen, B; McManus, GJ; Mohan, B; Shanmugaraju, S; Umadevi, D | 1 |
Kar, B; Paira, P | 1 |
Agrawal, S; Ghosh, C; Ghosh, K; Navale, G; Roy Choudhury, A; Roy, P; Sarkar, D; Singh, S | 1 |
Banerjee, S; De, S; Ghosh, A; Jenifer, SK; Kumar R, S; Kumar, SKA; Kuo, YC; Moorthy, A; Paira, P; Selvam, P | 1 |
Fuster, MG; García, G; Montalbán, MG; Moulefera, I; Pérez, J; Víllora, G | 1 |
Das, A; Mukherjee, S; Roy, S; Seal, I; Sil, S | 1 |
Argibay-Otero, S; García-Fontán, S; Martínez-Estévez, M; Prieto, I; Vázquez-López, EM | 1 |
Czerwonka, G; Gałczyńska, K; Jabłońska-Wawrzycka, A; Kalinowska-Tłuścik, J; Karpiel, M; Kazimierczuk, K; Klika, KD; Michałkiewicz, S; Rogala, P | 1 |
Al Nasr, IS; Gürbüz, N; Hamdi, N; Khan, TA; Koko, WS; Özdemir, I | 1 |
Agrawal, S; Choudhury, AR; Ghosh, K; Navale, GR; Sarkar, D; Sarma, M; Singh, HK; Singh, S; Singla, L | 1 |
Batista, AA; Brito, RDS; de Araujo-Neto, JH; Ellena, J; Guedes, APM; Leite, CM; Mello-Andrade, F; Moraes, CAF; Rocha, TL; Santos, AL | 1 |
Biswas, S; Chakraborty, S; Golding, TM; Omondi, RO; Prince, S; Smith, GS | 1 |
Arakelyan, J; Babak, MV; Grgurić-Šipka, S; Kraynik, YI; Kushnarev, V; Mutasim Alfadul, S; Nikolić, S; Stanković, D | 1 |
Bai, L; Chen, Y; Peng, X; Tang, Q; Zhao, H; Zhu, H | 1 |
Dharmasivam, M; Dorairaj, DP; Echeverria, C; Haribabu, J; Karvembu, R; Malekshah, RE; Mohamed Subarkhan, MK | 1 |
89 other study(ies) available for ruthenium and 4-cymene
Article | Year |
---|---|
Preparation of polymer-supported Ru-TsDPEN catalysts and use for enantioselective synthesis of (S)-fluoxetine.
Topics: Catalysis; Cymenes; Ethylenediamines; Fluoxetine; Molecular Structure; Monoterpenes; Polymers; Ruthenium; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Toluene | 2005 |
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Topics: Animals; Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Cell Nucleus; Chelating Agents; Crystallography, X-Ray; Cymenes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Ligands; Mice; Molecular Structure; Monoterpenes; Organometallic Compounds; Oxazines; Ruthenium | 2007 |
Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes.
Topics: Anthracenes; Base Pair Mismatch; Base Sequence; Binding Sites; Cymenes; DNA; DNA Adducts; DNA Damage; Escherichia coli; Ethylenediamines; Intercalating Agents; Molecular Structure; Monoterpenes; MutS DNA Mismatch-Binding Protein; Organometallic Compounds; Protein Binding; Ruthenium; Structure-Activity Relationship | 2008 |
Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.
Topics: Anti-Bacterial Agents; Benzaldehydes; Benzodioxoles; Cell Line, Tumor; Crystallography, X-Ray; Cymenes; DNA; Humans; Inhibitory Concentration 50; Ligands; Monoterpenes; Organometallic Compounds; Ruthenium; Thiosemicarbazones | 2011 |
Chemically engineered papain as artificial formate dehydrogenase for NAD(P)H regeneration.
Topics: 2,2'-Dipyridyl; Benzene; Cymenes; Ethylenediamines; Formate Dehydrogenases; Monoterpenes; NADP; Organometallic Compounds; Oxidation-Reduction; Papain; Phenanthrolines; Ruthenium | 2011 |
Excellent correlation between drug release and portal size in metalla-cage drug-delivery systems.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cymenes; Drug Delivery Systems; Endocytosis; Humans; Ligands; Magnetic Resonance Spectroscopy; Molecular Structure; Monoterpenes; Organometallic Compounds; Pyrenes; Ruthenium; Triazines; Water | 2011 |
A convenient and general ruthenium-catalyzed transfer hydrogenation of nitro- and azobenzenes.
Topics: Aniline Compounds; Azo Compounds; Catalysis; Cymenes; Hydrogenation; Molecular Structure; Monoterpenes; Nitrobenzenes; Organometallic Compounds; Ruthenium | 2011 |
Synthesis, reactivity studies, structural aspects, and solution behavior of half sandwich ruthenium(II) N,N',N''-triarylguanidinate complexes.
Topics: Crystallography, X-Ray; Cymenes; Guanidine; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Monoterpenes; Organometallic Compounds; Ruthenium | 2012 |
Investigation of the reactivity between a ruthenium hexacationic prism and biological ligands.
Topics: Amino Acids; Antineoplastic Agents; Arginine; Ascorbic Acid; Cymenes; Cysteine; Disulfides; Glucose; Glutathione; Ligands; Lysine; Magnetic Resonance Spectroscopy; Methionine; Monoterpenes; Organomercury Compounds; Oxidation-Reduction; Ruthenium; Solutions; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds | 2012 |
Preparation of organometallic ruthenium-arene-diaminotriazine complexes as binding agents to DNA.
Topics: Animals; CHO Cells; Coordination Complexes; Cricetinae; Cricetulus; Crystallography, X-Ray; Cymenes; DNA; Molecular Conformation; Monoterpenes; Ruthenium; Triazines | 2012 |
Well-defined ruthenium(II) carboxylate as catalyst for direct C-H/C-O bond arylations with phenols in water.
Topics: Carboxylic Acids; Catalysis; Cymenes; Molecular Structure; Monoterpenes; Phenols; Ruthenium; Water | 2012 |
Highly selective intramolecular carbene insertion into primary C-H bond of α-diazoacetamides mediated by a (p-cymene)ruthenium(II) carboxylate complex.
Topics: Acetamides; Azo Compounds; Carboxylic Acids; Coordination Complexes; Cymenes; Methane; Models, Molecular; Monoterpenes; Ruthenium | 2012 |
Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Coordination Complexes; Cymenes; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Monoterpenes; Ruthenium; Structure-Activity Relationship; Sulfides; Sulfones; Sulfoxides; X-Ray Diffraction | 2012 |
3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; Drug Stability; Flavonoids; Humans; Ligands; Monoterpenes; Quinolones; Ruthenium; Structure-Activity Relationship | 2013 |
Position-selective intramolecular aromatic C-H bond activation of 1,2,3-triazol-5-ylidene (tzNHC) ligands in (p-cymene)ruthenium(II) complexes.
Topics: Cymenes; Ligands; Models, Molecular; Molecular Structure; Monoterpenes; Organometallic Compounds; Ruthenium; Triazoles | 2013 |
New insight into the role of a base in the mechanism of imine transfer hydrogenation on a Ru(II) half-sandwich complex.
Topics: Circular Dichroism; Coordination Complexes; Cymenes; Hydrogenation; Imines; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Monoterpenes; Ruthenium; Spectroscopy, Fourier Transform Infrared | 2013 |
A ruthenium(II) arene complex showing emission enhancement and photocleavage activity towards DNA from singlet and triplet excited states respectively.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Cymenes; DNA; DNA Cleavage; Humans; Light; Monoterpenes; Photolysis; Ruthenium; Singlet Oxygen | 2013 |
Comparing the suitability of autodock, gold and glide for the docking and predicting the possible targets of Ru(II)-based complexes as anticancer agents.
Topics: Antineoplastic Agents; Binding Sites; Computational Biology; Coordination Complexes; Cymenes; Gold; Humans; Ligands; Macromolecular Substances; Molecular Structure; Monoterpenes; Ruthenium | 2013 |
Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
Topics: Antineoplastic Agents; Chlorides; Coordination Complexes; Cymenes; Drug Stability; Hydrogen-Ion Concentration; Ions; Magnetic Resonance Spectroscopy; Models, Molecular; Monoterpenes; Oxygen; Quantum Theory; Ruthenium; Solutions; Sulfur | 2013 |
Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
Topics: Animals; Antineoplastic Agents; Cattle; Coordination Complexes; Cymenes; DNA; Female; Humans; Intercalating Agents; Models, Molecular; Monoterpenes; Ovarian Neoplasms; Ovary; Ruthenium; Triazines | 2013 |
Ru-catalyzed 1,4-addition of arylboronic acids to acrylic acid derivatives in the presence of phenols.
Topics: Acrylates; Boronic Acids; Catalysis; Cymenes; Monoterpenes; Phenols; Ruthenium | 2013 |
New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
Topics: Animals; Anthracenes; Apoptosis; Cattle; Coordination Complexes; Crystallography, X-Ray; Cycloparaffins; Cymenes; DNA; DNA Cleavage; Humans; Hydrogen Peroxide; Hydrophobic and Hydrophilic Interactions; Intercalating Agents; Ligands; MCF-7 Cells; Molecular Conformation; Monoterpenes; Protein Binding; Quantum Theory; Ruthenium; Serum Albumin, Bovine | 2014 |
Synthesis of imine and reduced imine compounds containing aromatic sulfonamide: use as catalyst for in situ generation of ruthenium catalysts in transfer hydrogenation of acetophenone derivatives.
Topics: Acetophenones; Catalysis; Cymenes; Hydrogenation; Imines; Monoterpenes; Oxidation-Reduction; Ruthenium; Sulfonamides | 2014 |
Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cymenes; DNA; Humans; Kinetics; Ligands; Molecular Structure; Monoterpenes; Protein Binding; Proteins; Ruthenium | 2014 |
Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cymenes; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Molecular Conformation; Monoterpenes; Neoplasms; Organometallic Compounds; Pyridines; Ruthenium | 2014 |
Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Coordination Complexes; Cymenes; DNA; Female; Ferrous Compounds; Humans; Metallocenes; Monoterpenes; Naphthoquinones; Ruthenium; Uterine Cervical Neoplasms | 2014 |
Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Cymenes; DNA; Humans; Lung Neoplasms; Models, Molecular; Monoterpenes; Photochemotherapy; Photosensitizing Agents; Pyridines; Quinoxalines; Ruthenium | 2014 |
Why p-Cymene? Conformational effect in asymmetric hydrogenation of aromatic ketones with a η(6) -arene/ruthenium(II) catalyst.
Topics: Catalysis; Crystallography, X-Ray; Cymenes; Hydrogenation; Ketones; Molecular Conformation; Monoterpenes; Ruthenium; Static Electricity; Stereoisomerism; Thermodynamics | 2015 |
Fine control on the photochemical and photobiological properties of Ru(II) arene complexes.
Topics: Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; DNA; Humans; Ligands; Light; Magnetic Resonance Spectroscopy; Monoterpenes; Photolysis; Pyridines; Quinoxalines; Ruthenium; Superoxides | 2015 |
Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Coordination Complexes; Crystallography, X-Ray; Cymenes; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ruthenium | 2015 |
A combined experimental and computational study on the cycloisomerization of 2-ethynylbiaryls catalyzed by dicationic arene ruthenium complexes.
Topics: Biphenyl Compounds; Catalysis; Coordination Complexes; Cymenes; Isomerism; Monoterpenes; Phenanthrenes; Ruthenium | 2015 |
In vitro effects of binuclear (η (6)-p-cymene)ruthenium(II) complex containing bridging bis(nicotinate)-polyethylene glycol ester ligand on differentiation pathways of murine Th lymphocytes activated by T cell mitogen.
Topics: Animals; Cell Differentiation; Cell Survival; Coordination Complexes; Cymenes; Esters; Immunoblotting; Mice; Mitogens; Models, Molecular; Monoterpenes; Polyethylene Glycols; Polymerase Chain Reaction; Ruthenium; T-Lymphocytes, Helper-Inducer | 2015 |
Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.
Topics: Antineoplastic Agents; Cathepsin B; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Cymenes; DNA; Gold; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ruthenium | 2015 |
Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Colorectal Neoplasms; Cymenes; Drug Screening Assays, Antitumor; Endothelium, Vascular; Female; HEK293 Cells; Humans; Immunoenzyme Techniques; Mice; Models, Molecular; Monoterpenes; Neovascularization, Pathologic; Organometallic Compounds; Ovarian Neoplasms; Ruthenium; Structure-Activity Relationship | 2015 |
Anticancer Organometallic Osmium(II)-p-cymene Complexes.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chemistry Techniques, Synthetic; Chick Embryo; Chorioallantoic Membrane; Crystallography, X-Ray; Cymenes; Drug Screening Assays, Antitumor; Endothelial Cells; HEK293 Cells; Humans; Monoterpenes; Organometallic Compounds; Osmium Compounds; Ruthenium | 2015 |
Enantioselective addition of arylboronic acids to methyl 2-formylbenzoates by using a ruthenium/Me-BIPAM catalyst for synthesis of chiral 3-aryl-isobenzofuranones.
Topics: Benzoates; Boronic Acids; Catalysis; Cymenes; Furans; Methylation; Monoterpenes; Ruthenium; Stereoisomerism | 2015 |
Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cymenes; Female; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ovarian Neoplasms; Ruthenium; Thiazoles; Transcriptome | 2015 |
Interactions of two cytotoxic organoruthenium(II) complexes with G-quadruplex.
Topics: Adamantane; Antineoplastic Agents; Binding Sites; Coordination Complexes; Crystallography, X-Ray; Cymenes; Deuterium; G-Quadruplexes; Magnetic Resonance Spectroscopy; Molecular Conformation; Monoterpenes; Nucleic Acid Denaturation; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Ultraviolet Rays | 2016 |
Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Topics: A549 Cells; Antineoplastic Agents; Cations, Divalent; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Coordination Complexes; Cymenes; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Intercalating Agents; Monoterpenes; Organometallic Compounds; Phenanthrolines; Phenazines; Ruthenium; S Phase Cell Cycle Checkpoints; Solubility | 2016 |
Unusual dimer formation of cyclometalated ruthenium NHC p-cymene complexes.
Topics: Cymenes; Dimerization; Models, Molecular; Molecular Conformation; Monoterpenes; Organometallic Compounds; Ruthenium | 2016 |
[(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
Topics: Antineoplastic Agents; Cations, Divalent; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Cymenes; gamma-Aminobutyric Acid; Guanine; HCT116 Cells; HeLa Cells; Humans; Hydroxamic Acids; MCF-7 Cells; Models, Molecular; Monoterpenes; Organometallic Compounds; Ruthenium | 2016 |
A novel dual-functioning ruthenium(II)-arene complex of an anti-microbial ciprofloxacin derivative - Anti-proliferative and anti-microbial activity.
Topics: A549 Cells; Anti-Bacterial Agents; Antineoplastic Agents; Cations, Divalent; Cell Line, Tumor; Ciprofloxacin; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Cymenes; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Escherichia coli; HCT116 Cells; Humans; Monoterpenes; Organometallic Compounds; Ruthenium; Tumor Suppressor Protein p53 | 2016 |
Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chlorambucil; Cymenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Molecular Conformation; Monoterpenes; Neoplasms, Experimental; Organometallic Compounds; Ruthenium; Structure-Activity Relationship; Sulfhydryl Compounds | 2016 |
Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexes.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 7; Cell Cycle Checkpoints; Cell Line; Cell Survival; Coordination Complexes; Cymenes; DNA Fragmentation; Erythrocytes; Glutathione; Half-Life; Hemolysis; Humans; Hydrolysis; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Molecular Conformation; Monoterpenes; Ruthenium; Schiff Bases | 2016 |
Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; Cyclopentanes; Cymenes; Dendrimers; DNA; HEK293 Cells; Humans; Iridium; Models, Molecular; Monoterpenes; Pyridines; Rhodium; Ruthenium; Schiff Bases | 2016 |
Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; Drug Resistance, Neoplasm; Glutathione; Humans; Monoterpenes; Naphthoquinones; Ruthenium | 2016 |
The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Benzene; Benzene Derivatives; Cell Line, Tumor; Coordination Complexes; Curcumin; Cymenes; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; MCF-7 Cells; Monoterpenes; Organ Specificity; Ruthenium; Structure-Activity Relationship | 2016 |
Cytotoxic hydrogen bridged ruthenium quinaldamide complexes showing induced cancer cell death by apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Coordination Complexes; Cymenes; Humans; Hydrogen; Monoterpenes; Ruthenium | 2016 |
Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity.
Topics: Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Clioquinol; Cymenes; Enzyme Inhibitors; Humans; Monoterpenes; Neoplasm Invasiveness; Neoplasms; Organometallic Compounds; Ruthenium | 2016 |
Self-Assembly of Discrete Ru
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Cymenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Models, Molecular; Molecular Structure; Monoterpenes; Ruthenium; Structure-Activity Relationship | 2017 |
Metal NHC Complexes with Naphthalimide Ligands as DNA-Interacting Antiproliferative Agents.
Topics: Apoptosis; Cell Proliferation; Circular Dichroism; Coordination Complexes; Crystallography, X-Ray; Cymenes; DNA; Drug Stability; HT29 Cells; Humans; Intercalating Agents; Ligands; MCF-7 Cells; Methane; Molecular Conformation; Monoterpenes; Naphthalimides; Rhodium; Ruthenium; Spectrophotometry, Ultraviolet | 2017 |
Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cymenes; Drug Stability; Glutathione; Guanine; Humans; Hydrolysis; Ligands; Molecular Docking Simulation; Monoterpenes; Organometallic Compounds; Protein Conformation; Ruthenium; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes.
Topics: Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Cymenes; Drug Stability; Electrochemical Techniques; Humans; Imines; Ligands; Models, Chemical; Monoterpenes; Quantum Theory; Ruthenium; Solubility; Valproic Acid; Water | 2018 |
Coordination-driven self-assembly of ruthenium(ii) architectures: synthesis, characterization and cytotoxicity studies.
Topics: A549 Cells; Aminopyrine; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Survival; Coordination Complexes; Cymenes; HeLa Cells; Humans; Inhibitory Concentration 50; Mesylates; Molecular Structure; Monoterpenes; Ruthenium | 2018 |
Versatile coordination of acetazolamide to ruthenium(ii) p-cymene complexes and preliminary cytotoxicity studies.
Topics: Acetazolamide; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; HEK293 Cells; Humans; Monoterpenes; Ruthenium | 2018 |
Ru
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Cymenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Monoterpenes; Ruthenium; Structure-Activity Relationship; Zebrafish | 2018 |
Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
Topics: Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Cymenes; Drug Screening Assays, Antitumor; Humans; Ligands; Models, Molecular; Molecular Structure; Monoterpenes; Neuroblastoma; Ruthenium | 2018 |
Cytotoxic Ru
Topics: Antineoplastic Agents; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; Coordination Complexes; Cymenes; Drug Stability; Glutathione; Halogens; Humans; Imidazoles; Kinetics; Ligands; Membrane Potential, Mitochondrial; Monoterpenes; Ruthenium | 2019 |
Half-sandwich Ru(η
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; DNA; Guanine; Humans; Intercalating Agents; Ligands; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Ruthenium | 2019 |
Luminescent anticancer ruthenium(ii)-p-cymene complexes of extended imidazophenanthroline ligands: synthesis, structure, reactivity, biomolecular interactions and live cell imaging.
Topics: Antineoplastic Agents; Cell Survival; Coordination Complexes; Cymenes; Dose-Response Relationship, Drug; HeLa Cells; Humans; Ligands; Luminescent Agents; Molecular Structure; Optical Imaging; Phenanthrolines; Ruthenium; Structure-Activity Relationship | 2019 |
Covalent versus Noncovalent Binding of Ruthenium η
Topics: Antineoplastic Agents; Cymenes; Ligands; Monoterpenes; Ruthenium; Zinc Fingers | 2019 |
Solution equilibrium, structural and cytotoxicity studies on Ru(η
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Coordination Complexes; Copper; Cymenes; Female; Humans; Liver Neoplasms; Organometallic Compounds; Pyrazoles; Ruthenium; Thiosemicarbazones; Tumor Cells, Cultured | 2020 |
Inhibition of 3D colon cancer stem cell spheroids by cytotoxic Ru
Topics: Aminosalicylic Acids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Cymenes; Drug Screening Assays, Antitumor; Drug Stability; G2 Phase Cell Cycle Checkpoints; Humans; Kruppel-Like Factor 4; Ligands; Neoplastic Stem Cells; Ruthenium; Spheroids, Cellular | 2020 |
Effect of
Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Cymenes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Ligands; Membrane Potential, Mitochondrial; Models, Molecular; Molecular Structure; Ruthenium; Tyramine | 2020 |
Synthesis, characterization, theoretical, molecular docking and
Topics: Aniline Compounds; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Cymenes; Humans; Molecular Docking Simulation; Molecular Structure; Organoselenium Compounds; Ruthenium; Urea | 2021 |
Topics: Aminophenols; Antineoplastic Agents; Apoptosis; Cell Proliferation; Coordination Complexes; Cymenes; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Nitriles; Pyridazines; Pyridines; Ruthenium | 2020 |
DNA targeting half sandwich Ru(II)-
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; DNA; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Conformation; Molecular Imaging; Ruthenium; Stereoisomerism; Structure-Activity Relationship | 2021 |
Tracing the anticancer compound [Ru
Topics: Coordination Complexes; Cymenes; Humans; Mass Spectrometry; Ruthenium | 2021 |
Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II)
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Coordination Complexes; Cymenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Membrane Potential, Mitochondrial; Molecular Structure; Ruthenium; Schiff Bases; Structure-Activity Relationship; Sulfonamides; Tumor Cells, Cultured | 2021 |
Synthesis, characterization, interactions with 9-MeG and cytotoxic activity of heterobimetallic Ru
Topics: Animals; Antineoplastic Agents; Cisplatin; Coordination Complexes; Cymenes; Guanine; HeLa Cells; Humans; Hydrolysis; Magnetic Resonance Spectroscopy; MCF-7 Cells; Mice; NIH 3T3 Cells; Platinum; Pyrimidines; Ruthenium; Spectrometry, Mass, Electrospray Ionization | 2021 |
GSH-resistant and highly cytoselective ruthenium(II)-
Topics: Caco-2 Cells; Cymenes; Humans; Phenol; Ruthenium | 2021 |
Impact of aliphatic acyl and aromatic thioamide substituents on the anticancer activity of Ru(II)-
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Cell Survival; Coordination Complexes; Cymenes; Female; Human Umbilical Vein Endothelial Cells; Humans; Intestinal Absorption; Ligands; Male; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Ruthenium; Thioamides; Thiourea | 2021 |
[Ru(η
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Carcinoma; Cell Line, Tumor; Chemistry, Pharmaceutical; Coordination Complexes; Cymenes; Humans; Oxyquinoline; Ruthenium; Tissue Distribution; Zebrafish | 2022 |
Nanoencapsulation of Ru(
Topics: Antineoplastic Agents; Biological Products; Caspases; Cell Line, Tumor; Cell Proliferation; Cymenes; Humans; Liposomes; Melanoma; Molecular Structure; Organometallic Compounds; Prospective Studies; Ruthenium; Zingiber officinale | 2022 |
Design, Synthesis, and Anticancer Studies of a
Topics: 1-Naphthylamine; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Curcumin; Cymenes; Humans; Naphthalimides; Quinolones; Ruthenium; Spectroscopy, Fourier Transform Infrared | 2022 |
One pot three component synthesis of DNA targeting phototoxic Ru(II)-
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Dimethyl Sulfoxide; DNA; Phenazines; Reactive Oxygen Species; Ruthenium; Serum Albumin | 2022 |
DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(II) complexes.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; DNA; HEK293 Cells; Humans; Ruthenium | 2022 |
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; DNA; Humans; Imidazoles; Ligands; Molecular Structure; Pyridines; Quinolines; Ruthenium | 2022 |
Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; HeLa Cells; Humans; Neoplasms; Ruthenium | 2022 |
A toxicological evaluation for safety assessment of ruthenium-based diosmetin complex in rats.
Topics: Animals; Female; Flavonoids; Male; Mutagens; Rats; Ruthenium; Toxicity Tests, Acute | 2023 |
Synthesis, Characterization, and Cytotoxicity Studies of N-(4-Methoxybenzyl) Thiosemicarbazone Derivatives and Their Ruthenium(II)-
Topics: Chlorides; Ligands; Ruthenium; Salts; Thiosemicarbazones | 2022 |
Synthesis, Characterization and Biological Investigations of Half-Sandwich Ruthenium(II) Complexes Containing Benzimidazole Moiety.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Coordination Complexes; Escherichia coli; Humans; Molecular Docking Simulation; Ruthenium; Staphylococcus aureus | 2022 |
Evaluation of Ruthenium(II)
Topics: Anti-Infective Agents; Antineoplastic Agents; Antioxidants; Coordination Complexes; Ligands; Ruthenium | 2023 |
Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid β (1-42) peptide aggregation.
Topics: Amyloid; Amyloid beta-Peptides; Amyloidogenic Proteins; Coordination Complexes; Humans; Molecular Docking Simulation; Protein Aggregates; Ruthenium | 2023 |
"Half-Sandwich" Ruthenium Complexes with Alizarin as Anticancer Agents:
Topics: Animals; Anthraquinones; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Molecular Structure; Ruthenium; Zebrafish | 2023 |
Quinolyl-Based PGM Metallarectangles: Antiproliferative Activity, DNA and BSA Protein Interactions, and a Molecular Docking Perspective.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA; Female; Humans; Ligands; MCF-7 Cells; Molecular Docking Simulation; Quinolines; Ruthenium; Serum Albumin, Bovine | 2023 |
Coordination of Ru(II)-Arene Fragments to Dipyridophenazine Ligands Leads to the Modulation of Their In Vitro and In Vivo Anticancer Activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Cymenes; Ligands; Mice; Ruthenium | 2023 |
Study on antitumor activity of three ruthenium arene complexes in vitro.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA; HeLa Cells; Humans; Ruthenium | 2023 |
Ru(II)-
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Cymenes; Ligands; Mice; Neoplasms; Ruthenium | 2023 |